# Evaluation of Polygenic Risk Scores for Prediction of Coronary Artery Disease in a Greek Case-Control Study

## TL;DR

This study evaluates how well polygenic risk scores predict coronary artery disease in a Greek population, finding one score particularly effective.

## Contribution

The study identifies PGS000747 as a highly effective polygenic risk score for CAD prediction in a Greek case-control sample.

## Key findings

- PGS000747 increased CAD risk prediction by 21.6% (p = 2.63 × 10−25).
- PGS000012 showed a modest 2.2% increase in CAD risk (p = 9.58 × 10−4).
- PGS000747 demonstrated remarkable risk discrimination capability.

## Abstract

Coronary artery disease (CAD) stands as the most predominant type of cardiovascular disease (CVD). Polygenic risk scores (PRSs) have become essential tools for quantifying genetic susceptibility, and researchers endeavor to improve their predictive precision. The aim of the present work is to assess the performance and the relative contribution of PRSs developed for CVD or CAD within a Greek population. The sample under study comprised 924 Greek individuals (390 cases with CAD and 534 controls) from the THISEAS study. Nine PRSs drawn from the PGS catalog were replicated and tested for CAD risk prediction. PRSs computations were performed in the R language, and snpStats was used to process genotypic data. Descriptive characteristics of the study were analyzed using the statistical software IBM SPSS Statistics v21.0. The effectiveness of each PRS was assessed using the PRS R2 metric provided by PRSice2. Among nine PRSs, PGS000747 greatly increased the predictive value of primary CAD risk factors by 21.6% (p-value = 2.63 × 10−25). PGS000012 was associated with a modest increase in CAD risk by 2.2% (p-value = 9.58 × 10−4). The remarkable risk discrimination capability of PGS000747 stands out as the most noteworthy outcome of our study.